Generic drug

Results: 2111



#Item
881Medicine / Pharmaceutical industry / Generic drug / Public domain / Pharmacy / Modafinil / Copayment / Ciprofloxacin / Tom DeLay / Pharmacology / Pharmaceutical sciences / Pharmaceuticals policy

Microsoft Word - Mike Russo USPIRG Testimony on Pay-for-Delay Deals

Add to Reading List

Source URL: uspirg.org

Language: English - Date: 2013-07-22 16:37:03
882Health / Food and Drug Administration / Food law / Pharmacology / Pharmaceutical industry / Abbreviated New Drug Application / Generic drug / Federal Food /  Drug /  and Cosmetic Act / Prescription Drug User Fee Act / Pharmaceuticals policy / Pharmaceutical sciences / Medicine

H. R[removed]One Hundred Tenth Congress of the United States of America AT T H E S E C O N D S E S S I O N

Add to Reading List

Source URL: www.fda.gov.

Language: English
883Pharmacology / Clinical research / Generic drug / Public domain / Abbreviated New Drug Application / Food and Drug Administration / Pharmaceutical sciences / Pharmaceuticals policy / Pharmaceutical industry

Stability – The Current Status Susan Rosencrance, Ph.D. Deputy Director for Chemistry (Acting) Office of Generic Drugs GPhA/FDA Fall Technical Conference

Add to Reading List

Source URL: www.fda.gov.

Language: English
884Pharmaceutical sciences / Prescription Drug User Fee Act / Center for Biologics Evaluation and Research / New Drug Application / Investigational New Drug / FDA Special Protocol Assessment / Center for Drug Evaluation and Research / Biologic / Generic drug / Food and Drug Administration / Medicine / Health

Revisions to Guidance to Industry 2125fnl.PDF

Add to Reading List

Source URL: www.fda.gov.

Language: English
885Health / Pharmaceutical industry / Clinical research / Food and Drug Administration / Generic drug / Abbreviated New Drug Application / Center for Drug Evaluation and Research / Drug Price Competition and Patent Term Restoration Act / Kefauver Harris Amendment / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacology

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
886Clinical research / Clinical pharmacology / Pharmaceuticals policy / Generic drug / Abbreviated New Drug Application / Food and Drug Administration / Bioequivalence / New Drug Application / Drug discovery / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
887Research / Clinical research / Pharmaceutical industry / Bioequivalence / Pharmacokinetics / Generic drug / Center for Drug Evaluation and Research / Pharmaceutical sciences / Pharmacology / Food and Drug Administration

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
888Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / Generic drug / Drug Price Competition and Patent Term Restoration Act / Novartis / Patent / Adderall / Pfizer / Pharmaceutical sciences / Pharmacology / Health

Providing key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. IMPACT OF PATENT SETTLEMENTS

Add to Reading List

Source URL: www.gphaonline.org

Language: English - Date: 2013-07-09 11:42:00
889Pharmacology / Pharmaceuticals policy / Food and Drug Administration / Abbreviated New Drug Application / Generic drug / Regulatory science / Center for Drug Evaluation and Research / Drug development / Pharmaceutical sciences / Pharmaceutical industry / Clinical research

Complex Generic Drugs Robert Lionberger, Ph.D. Deputy Director for Science (acting) Office of Generic Drugs Center for Drug Evaluation and Research, FDA The views presented are those of the authors and do not necessarily

Add to Reading List

Source URL: www.fda.gov

Language: English
890Pharmaceuticals policy / Biosimilar / Biotechnology / Drugs / Pharmaceutical industry / Biologic / Food and Drug Administration / Hospira / Generic drug / Pharmaceutical sciences / Pharmacology / Clinical research

Lifesaving Drugs at Lower Costs Introduction The Food and Drug Administration (FDA) began approving generic (unbranded) prescription drugs around 30 years ago, and generic drugs are now saving consumers more than one tri

Add to Reading List

Source URL: www.theamericanconsumer.org

Language: English - Date: 2014-10-17 12:07:50
UPDATE